|
|
|
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.CN |
First Approval Date01 Jan 1966 |
[Translation] Pharmacokinetic study of ibuprofen injection in humans
考察健康受试者单次和多次恒速静脉输注试验药物布洛芬注射液(海南合瑞制药股份有限公司,规格:4mL:400mg)的人体药代动力学特征,为试验药物布洛芬注射液的生产报批、临床应用中的有效性和安全性提供依据。
[Translation] To investigate the human pharmacokinetic characteristics of the test drug ibuprofen injection (Hainan Herui Pharmaceutical Co., Ltd., specification: 4mL:400mg) by single and multiple constant-rate intravenous infusion in healthy subjects, which is the test drug ibuprofen Provide evidence for the production approval, efficacy and safety of Fen injection in clinical application.
评价布洛芬注射液治疗术后中、重度疼痛有效性和安全性的随机、双盲、安慰剂平行对照、多中心临床研究
[Translation] A randomized, double-blind, placebo-controlled, multicenter clinical study evaluating the efficacy and safety of ibuprofen injection in the treatment of moderate and severe postoperative pain
评价布洛芬注射液辅助治疗腹部或骨科术后中、重度疼痛的有效性和安全性。
[Translation] To evaluate the efficacy and safety of ibuprofen injection adjunctive treatment of moderate and severe pain after abdominal or orthopedic surgery.
[Translation] Pharmacokinetic study of ibuprofen injection in humans
对布洛芬注射液(4mL:0.4g)进行健康人体内药代动力学研究,测定布洛芬的经时血药浓度,计算主要药代动力学参数,了解布洛芬注射液在健康人体内的吸收、分布、消除规律,为该药的申报及临床应用提供依据。
[Translation] Pharmacokinetic study of ibuprofen injection (4mL: 0.4g) in healthy people was carried out, the blood concentration of ibuprofen was measured over time, and the main pharmacokinetic parameters were calculated to understand the effect of ibuprofen injection in healthy people. The laws of absorption, distribution and elimination in the body provide the basis for the application and clinical application of the drug.
100 Clinical Results associated with Hainan Zhengrui Pharmaceutical Technology Development Co Ltd
0 Patents (Medical) associated with Hainan Zhengrui Pharmaceutical Technology Development Co Ltd
100 Deals associated with Hainan Zhengrui Pharmaceutical Technology Development Co Ltd
100 Translational Medicine associated with Hainan Zhengrui Pharmaceutical Technology Development Co Ltd